Literature DB >> 8279888

Surgical treatment of lung cancer in the octogenarian.

T Osaki1, T Shirakusa, M Kodate, R Nakanishi, T Mitsudomi, H Ueda.   

Abstract

The purpose of this study was to investigate the value of surgical treatment for lung cancer in the octogenarian. Thirty-three patients 80 years of age or older (mean age, 82.4; range, 80 to 92 years; 25 men, 8 women) underwent surgical resection in our units between 1974 and 1991. The operative mortality rate was 3%, and the 5-year survival rate was 32%. The relative 5-year survival rate (survival rate of our subjects/that of matched population) was 61%. The mortality and long-term survival rates were similar to those in younger patients. In this study, long-term survival had no significant dependence on stage of disease, histologic tumor type, or complete versus incomplete resection. It was dependent mainly on postoperative complications, in particular, cardiorespiratory complications (cardiac complications, p = 0.0005; respiratory complications, p < 0.05). These data suggest that the octogenarian who suffers from lung cancer deserves the opportunity for a cure and the long-term benefits of surgical treatment, on the condition that no postoperative major cardiorespiratory complications set in.

Entities:  

Mesh:

Year:  1994        PMID: 8279888     DOI: 10.1016/0003-4975(94)90392-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Treatment of the postoperative recurrence of lung cancer in octogenarians.

Authors:  Manabu Yasuda; Akira Nagashima; Akira Haro; Genkichi Saitoh
Journal:  Surg Today       Date:  2013-09-12       Impact factor: 2.549

Review 2.  Surgical treatment of non-small-cell lung cancer in octogenarians.

Authors:  Miguel Guerra; Paulo Neves; José Miranda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-08

Review 3.  Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014.

Authors:  Noriyoshi Sawabata; Takashi Nagayasu; Yoshihisa Kadota; Taichiro Goto; Hiroyoshi Horio; Takeshi Mori; Shinichi Yamashita; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-27

4.  Results of Lung Cancer Surgery for Octogenarians.

Authors:  Haruaki Hino; Tomohiro Murakawa; Junji Ichinose; Kazuhiro Nagayama; Junichi Nitadori; Masaki Anraku; Jun Nakajima
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-16       Impact factor: 1.520

5.  Surgical treatment for lung cancer in octogenarians.

Authors:  Masashi Muraoka; Tadayuki Oka; Shinji Akamine; Tsutomu Tagawa; Nobufumi Sasaki; Yasushi Ikuta; Masao Inoue; Takatomo Yamayoshi; Satoshi Hashizume; Yutaka Tagawa; Takeshi Nagayasu
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  Efficacy of functional operability algorithm for octogenarians with primary lung cancer.

Authors:  Hideo Umezu; Shinichiro Miyoshi; Osamu Araki; Yohko Karube; Motohiko Tamura; Satoru Kobayashi; Hiromi Ishihama; Masayuki Chida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

Review 7.  [Thoracic surgery in the elderly].

Authors:  H Dienemann; H Hoffmann; F Herth
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

8.  Impact of mediastinal lymph node dissection on octogenarians with non-small cell lung cancer.

Authors:  Shinjiro Mizuguchi; Kiyotoshi Inoue; Takashi Iwata; Nobuhiro Izumi; Takuma Tsukioka; Ryuhei Morita; Tatsuya Nishida; Noritoshi Nishiyama; Taichi Shuto; Shigefumi Suehiro
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-03

9.  [Surgical therapy of lung metastases-indications, technique, results].

Authors:  A Stier; C-D Heidecke
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

10.  Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.

Authors:  Nathan A Cannon; Puneeth Iyengar; Hak Choy; Robert Timmerman; Jeffrey Meyer
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.